Ken Griffin’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Ken Griffin’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,000	Closed	-$288K	–	10944
2020 Q1	$288K	Buy	6,000 +500	+9%	+$23.3K	﹤0.01%	7416
2019 Q4	$258K	Buy	+5,500	New	+$243K	﹤0.01%	7819

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Ken Griffin's RARX Position: Q2 2020 in Review

Ken Griffin sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 42,956 shares — an estimated $2.06M sold.

Ken Griffin first reported a position in RARX in Q3 2017 and held it in 10 quarters. The position peaked at $37.2M in Q4 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Ken Griffin reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Ken Griffin sold 42,956 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $2.06M.
Ken Griffin first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 10 quarters.
Ken Griffin's Ra Pharmaceuticals, Inc. Common Stock position peaked at $37.2M in Q4 2019.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.